TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Grade II-IV acute graft versus host disease (GVHD) survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in Pain Level
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Whole body sweat loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discovery of suitable biomarkers for squamous intraepithelial neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of newly identified, disease-specific Metabolic Fingerprints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Weight-for-age Z score (WAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Preparedness for Shared Decision Making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the Bayley IV age equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the GMFM-66
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in EEG brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Discontinuing Study Medication Due to an Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Discharge rate of patients with stable UGIB
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 7-Day Point Prevalent Abstinence Rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 60-day mortality from the day of randomization
Endpoint domain: Mortality/survival
Primary endpoint: Fugl-Meyer motor assessment upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinarm: visually guided reaching task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DeXtreme: reaching task - Market stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DeXtreme: reaching task - Alchemist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of immersive technologies experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Integration of virtual reality
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Acceptability of immersive technologies
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PSA Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F-18 PSMA PET/CT Scan findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Xerosis Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Associative learning test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Boston Bowel Readiness Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in ki67 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in P-gp level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: WOMAC pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Performance on clinical neurocognitive tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Adverse Events Related to the Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants remaining recurrence-free
Endpoint domain: Mortality/survival
Primary endpoint: Negative blood smear at Month 6 visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of participants with solicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with unsolicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with serious adverse events (SAEs), adverse events of special interest (AESIs), medically attended adverse events (MAAEs), and AEs leading to early termination
Endpoint domain: Adverse events/effects
Primary endpoint: Six Spot Step Test (SSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FICSIT-4 test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities-specific Balance Confidence scale (AsBC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Longitudinal change of 95th centile of stride velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Moderate-to-vigorous Intensity Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hemoglobin concentration difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patients' pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional rescue treatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Wartenberg Pendulum Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pressure pain threshold before intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pressure pain threshold after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Gastric mucosal manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of subjects with apparent radiographic fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functional Disability Index (FDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hippocampal M1 availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain knowledge and beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of Treatment-Emergent Liver Test Changes
Endpoint domain: Adverse events/effects
Primary endpoint: RSV-A neutralization titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RSV-B neutralization titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SARS-CoV-2 Omicron XBB.1.5 neutralization titers against pseudovirus bearing S protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients accomplishing the recommended regimen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pulmonary artery Pressure (PAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative excretion of 14C-labeled drug-related material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of the Proportion of different metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety assessed as number of adverse events related to study device for Step 1
Endpoint domain: Adverse events/effects
Primary endpoint: Safety assessed as number of adverse events related to study device for Step 2
Endpoint domain: Adverse events/effects
Primary endpoint: 7-day point prevalence abstinence (PPA) from all nicotine and tobacco use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clinical deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Recovery Capital per person
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in number of drug overdoses per person
Endpoint domain: Adverse events/effects
Primary endpoint: Change in number of days of illicit substance use per person
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in mechano-morphological muscle-tendon properties - muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in maximal isometric muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of life measured by SF-36 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life measured by Self-administered PCOSQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Body measurements using Measuring Tape
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian function index (CFI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Oxygen saturation performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to peripheral oxygen saturation (SpO2) of 95%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in Y balance test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Time Up and Go test seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in body awareness ratio score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in functionality score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Melatonin profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum tolerated dose (MTD) of SM08502
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermittent and Constant Osteoarthritis Pain (ICOAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number/incidence and percentage of subjects with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with MTD and RDE of HCB301
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian alignment based on diurnal heart rate variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional hand tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of cytokines in postprandial state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Evolution of inflammatory markers in postprandial state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: proportion of patients receiving BED 10 >50 Gy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: the incidence of radiation-induced brain necrosis
Endpoint domain: Adverse events/effects
Primary endpoint: cumulative incidence of non-relapse mortality
Endpoint domain: Mortality/survival
Primary endpoint: Percent Change in Steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent-Child Interaction Change at Home
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Social Communication Change
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Observation of Diagnostic Features of Autism Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Fluticasone Propionate (FP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Salmeterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t for Fluticasone Propionate (FP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t for Salmeterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-week survival
Endpoint domain: Mortality/survival
Primary endpoint: Abdominal compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUC) from time 0 to last measurable concentration (AUC0 - tau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUC) from time 0 to infinity (AUC0 - infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days Per Month Hazardous Drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe Sexual Assault (Revictimization)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Number of Key Presses When Watching Risk Video
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Latency to Choose to Leave a Videotaped Scenario (Seconds)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Composite clinical endpoint of adjudicated events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cognitive domain
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in relationship instability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in partner support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Falls Efficacy Scale - International
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Spinal Cord Injury Falls Concern Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wheelchair Use Confidence Scale v.3
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of Wheezing/Asthma like episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants using acid-reducing medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants having had reoperations due to GERD
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum Insulin-like Growth Factor Binding Protein-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in cortico-striatal connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived control over childbirth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of subjects with adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: QTcF: Baseline and placebo-adjusted QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients achieving left-bundle branch pacing at implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients meeting left-bundle branch pacing criteria at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of ESBL-E cross transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Nutrition Security
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Supplemental Nutrition Assistance Program (SNAP) Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence and Severity of Retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Numeric rating scale (NRS) for daily pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Global Impression of Change (PGIC) in pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Familiarity to human writing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Satisfaction for clinical use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hand Isokinetic Muscle Strength Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip Strength Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Evaluation: Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence, type, and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator-assessed pathologic complete response (inv-pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Time Spent Engaged in Light-Intensity Physical Activity at Work
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin D Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effectiveness of olfactory training therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viremia Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The dose suspension rate caused by drug-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: M-protein detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC and AUClast for CYP substrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of CorDial-S
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Affect Intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time of first incision pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Subgenual Cingulate Functional Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of injection site reactions (ISRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in serum blood parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Knowledge and attitude regarding emergency treatment of traumatic dental injuries
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant Muscular Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Participant Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Awareness and Current Practices Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the C-PSST
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of the C-PSST
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood Oxygenation Level Dependent (BOLD) fMRI signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gaze position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Behavioral response (button press)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in ERP amplitude (FN400)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in ERP amplitude (parietal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in retrieval memory accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in retrieval memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician perception of EBIS acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinician perception of EBIS feasibility and utility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EBIS feasibility as assessed by clinician retention statistics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time till the first postoperative analgesia demand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUCinf) of Lotiglipron
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in change of Total Symptom Interference Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants with Flexcare adoption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Technical Efficacy Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Social Communication Skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Adaptive Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Expressive Language
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rare Disease Specific Self-Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urine protein remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of gastroesophageal reflux disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes